The effects of single- and multiple-dose administration of bococizumab (RN316/PF-04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastati
2017 ◽
Vol 36
(1)
◽
pp. e12309
◽
2013 ◽
Vol 61
(10)
◽
pp. E1387
◽
1996 ◽
Vol 26
(3)
◽
pp. 308-315
◽
1984 ◽
Vol 259
(18)
◽
pp. 11512-11519
2005 ◽
Vol 74A
(4)
◽
pp. 722-738
◽
2013 ◽
Vol 76
(5)
◽
pp. 763-775
◽
Keyword(s):
1986 ◽
Vol 141
(3)
◽
pp. 1267-1273
◽
Keyword(s):